Publications by authors named "Portero B"
Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
Clin Transl Oncol
October 2022
Purpose: Immune Checkpoint Inhibitors (ICI) can be associated with thrombotic events, both venous and arterial (VTE/AT). However, there is a paucity of information regarding patients in routine clinical practice.
Methods/patients: Retrospective, multicenter study promoted by the Thrombosis and Cancer Section of the Spanish Society of Medical Oncology (SEOM).
Article Synopsis
- Thromboembolic complications are a significant issue in cancer patients, increasing both morbidity and mortality, prompting the Spanish Society of Medical Oncology to establish a registry for better understanding of cancer-associated thrombosis (CAT).
- The TESEO study is an ongoing, multicentric registry that tracks newly diagnosed thromboembolic events in adult cancer patients, focusing on various health conditions and treatment responses to enhance clinical management of CAT.
- The registry collects comprehensive data over time, monitoring outcomes like rethrombosis and survival to provide insights on how the prognosis for cancer patients changes based on the timing and context of thrombus occurrences.
The Expert Patients Program (EPP), an educational intervention for chronic diseases aimed at nonprofessionals, has high nonparticipation and dropout rates. We used quantitative and qualitative methods to identify the prevalence of and reasons for nonparticipation in 100 patients with acute myocardial infarction and 69 with stroke. We confirmed a high prevalence of refusal, identifying three groups based on degree of participation: patients who refused to attend (51%), patients who attended and then dropped out (10%), and patients who attended (39%).
View Article and Find Full Text PDF